SCHEMBL4601485

SCHEMBL4601485

Cc1cccc(-c2ccc(OC3CCCC3)c(C(=O)O)c2)c1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.58
PDE4B Q07343 3/20 0.58
PDE4C Q08493 3/20 0.58
PDE4D Q08499 3/20 0.58
SYK P43405 3/20 0.53
PDE5A O76074 1/20 0.47
PDE1A P54750 1/20 0.47
PDE1B Q01064 1/20 0.47
PDE1C Q14123 1/20 0.47
AKR1C2 P52895 1/20 0.47
AKR1C1 Q04828 1/20 0.47
GRIK1 P39086 2/20 0.47
DHODH Q02127 1/20 0.46
MKNK1 Q9BUB5 2/20 0.45
MKNK2 Q9HBH9 2/20 0.45
CFD P00746 1/20 0.44
FPR2 P25090 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4602161 0.85 PDE4D (0.62) PDE4APDE4BPDE4CPDE4DSYK
SCHEMBL4600365 0.82 PDE4A (0.72) PDE4APDE4BPDE4CPDE4DFPR2
SCHEMBL4601903 0.81 PDE4A (0.51) PDE4APDE4BPDE4CPDE4DSYK
SCHEMBL4601471 0.79 PDE4D (0.60) PDE4APDE4BPDE4CPDE4DSYK
SCHEMBL4601185 0.79 PDE4A (0.64) PDE4APDE4BPDE4CPDE4DSYK
SCHEMBL21939128 0.76 GRIK1 (0.55) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL4602098 0.76 PDE4A (0.48) PDE4APDE4BPDE4CPDE4DSYK
SCHEMBL4617281 0.76 AKR1C2 (0.51) AKR1C2AKR1C1DHODHMKNK1MKNK2
SCHEMBL4601409 0.76 PTPN11 (0.57) AKR1C2AKR1C1DHODHCFD
SCHEMBL8466183 0.75 PDE4A (0.74) PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO claimed
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R PDE4A 1576/4885PDE4B 1807/4885PDE4C 1726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.